Postoperative SpO₂/FiO₂ in Obese and Non-Obese Patients: Role of STOP-BANG

ConditionOxygen Deficiency

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorIstinye University

About this trial

The aim of this study is to evaluate the effect of the Reverse Trendelenburg position on oxygenation (SpO₂/FiO₂ ratio) in the early postoperative period in patients undergoing laparoscopic surgery. In our study, obesity is considered as a comparative subgroup in terms of variability of this effect; additionally, the STOP-BANG score, which measures the risk of obstructive sleep apnea syndrome, is examined as an auxiliary indicator.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients over 18 years old

Patients who give consent to participate in the study

Patients who underwent elective laparoscopic cholecystectomy in Reverse Trendelenburg (30 degrees) position

ASA I-III patients

Disqualifiers

Patients under 18 years old

Patients who did not give consent

Patients with asthma, COPD, or known respiratory disease

Patients whose procedure could not be completed or who had missing data

Trial population

Adults over 18, ASA I-III patients, patients who give consent to participate, patients undergoing elective laparoscopic surgery (obesity surgery, cholecystectomy, umbilical hernia, etc.)

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

oxygen deficiency
Behavioral
The aim of this study is to evaluate the effect of the Reverse Trendelenburg position on oxygenation (SpO₂/FiO₂ ratio) in the early postoperative period in patients undergoing laparoscopic surgery. In our study, obesity is considered as a comparative subgroup in terms of variability of this effect; additionally, the STOP-BANG score, which measures the risk of obstructive sleep apnea syndrome, is examined as an auxiliary indicator.

Treatment groups

64 Participants

are divided into 2 treatment groups

Group A: obese1 intervention

Group B: control1 intervention

Trial outcomes

Primary outcomes

oxygen level

SpO₂/FiO₂ ratio

Time frame

4 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Istinye University

Lead sponsor

Haseki Training and Research Hospital

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: